|
Market Closed -
Other stock markets
|
After hours 19:59:00 | |||
| 118.87 USD | +1.02% |
|
119.08 | +0.17% |
| 07-23 | JPMorgan Adjusts Price Target on Incyte to $110 From $105, Maintains Neutral Rating | MT |
| 07-22 | Morgan Stanley Adjusts Price Target on Incyte to $104 From $103, Maintains Equalweight Rating | MT |
Company Valuation: Incyte Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 16,213 | 17,869 | 14,072 | 13,306 | 19,391 | 23,748 | - | - |
| Change | - | 10.21% | -21.25% | -5.44% | 45.73% | 22.47% | - | - |
| Enterprise Value (EV) 1 | 13,865 | 14,630 | 10,416 | 11,148 | 16,293 | 19,741 | 17,821 | 15,623 |
| Change | - | 5.52% | -28.81% | 7.03% | 46.15% | 21.16% | -9.73% | -12.33% |
| P/E | 17.2x | 52.8x | 23.7x | 460x | 15.4x | 67.6x | 15.4x | 14.9x |
| PBR | 4.32x | 4.09x | 2.71x | 3.88x | 3.79x | 4.26x | 3.02x | 2.26x |
| PEG | - | -0.8x | 0.3x | -4.9x | 0x | -0.9x | 0x | 4.58x |
| Capitalization / Revenue | 5.43x | 5.26x | 3.81x | 3.14x | 3.77x | 4.15x | 3.84x | 3.7x |
| EV / Revenue | 4.64x | 4.31x | 2.82x | 2.63x | 3.17x | 3.45x | 2.88x | 2.43x |
| EV / EBITDA | 21.5x | 24.5x | 14.8x | 22.2x | 9.53x | 25.6x | 7.63x | 6.48x |
| EV / EBIT | 23.7x | 25.2x | 16.8x | 26.9x | 10.1x | 27.7x | 7.66x | 6.05x |
| EV / FCF | 24.4x | 16.4x | 22.4x | 44.8x | - | 27.1x | 9.63x | 8.58x |
| FCF Yield | 4.1% | 6.1% | 4.45% | 2.23% | - | 3.68% | 10.4% | 11.7% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 4.27 | 1.52 | 2.65 | 0.15 | 6.41 | 1.758 | 7.713 | 7.964 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,986 | 3,395 | 3,696 | 4,241 | 5,141 | 5,723 | 6,184 | 6,425 |
| EBITDA 1 | 643.6 | 597.7 | 703.2 | 503.1 | 1,709 | 770.4 | 2,336 | 2,413 |
| EBIT 1 | 585.8 | 579.4 | 620.5 | 413.9 | 1,616 | 712.3 | 2,325 | 2,584 |
| Net income 1 | 948.6 | 340.7 | 597.6 | 32.62 | 1,287 | 362.9 | 1,557 | 1,656 |
| Net Debt 1 | -2,348 | -3,239 | -3,656 | -2,158 | -3,098 | -4,007 | -5,927 | -8,125 |
| Reference price 2 | 73.40 | 80.32 | 62.79 | 69.07 | 98.77 | 118.87 | 118.87 | 118.87 |
| Nbr of stocks (in thousands) | 220,891 | 222,475 | 224,109 | 192,650 | 196,323 | 199,782 | - | - |
| Announcement Date | 2/8/22 | 2/7/23 | 2/13/24 | 2/10/25 | 2/10/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 67.61x | 3.45x | 25.63x | -.--% | 23.75B | |
| 17.64x | 3.78x | 9.76x | 0.58% | 67.88B | |
| 26.33x | 5.45x | 16.01x | 0.6% | 53.23B | |
| 37.7x | 12.83x | 24.43x | -.--% | 48.71B | |
| -43.2x | 3.1x | 9.18x | 3.5% | 38.98B | |
| 24.81x | 3.46x | 11.92x | -.--% | 29.55B | |
| -6.42x | 8.92x | -5.49x | -.--% | 22.07B | |
| -37.81x | 18.02x | -49.34x | -.--% | 16.49B | |
| 24.4x | 5.22x | 13.67x | -.--% | 16.57B | |
| -115.63x | 12.42x | -88.9x | -.--% | 12.27B | |
| Average | -0.46x | 7.67x | -3.31x | 0.47% | 32.95B | |
| Weighted average by Cap. | 10.05x | 6.71x | 6.75x | 0.63% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- INCY Stock
- Valuation Incyte Corporation
Select your edition
All financial news and data tailored to specific country editions
